ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bronchiectasis Drugs Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-2M6354
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Bronchiectasis Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Bronchiectasis Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-2M6354
Report
December 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Endo International Plc.
GlaxoSmithKline PLC
Neopharma, Inc.
Pfizer Inc
Reckitt Benckiser Group Plc.

Bronchiectasis Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Bronchiectasis Drugs Market

Bronchiectasis Drugs Market

Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bacteria in the lungs efficiently.
Market Analysis and Insights: Global Bronchiectasis Drugs Market
The global Bronchiectasis Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Bronchiectasis Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Bronchiectasis Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Bronchiectasis Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bronchiectasis Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Bronchiectasis Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Bronchiectasis Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Bronchiectasis Drugs Market Report

Report Metric Details
Report Name Bronchiectasis Drugs Market
CAGR 5%
Segment by Type
  • Antibiotics
  • Expectorants
  • Other drugs
Segment by Application
  • Hospital
  • Research institute
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Endo International Plc, GlaxoSmithKline Plc, Neopharma LLC, Pfizer Inc., Reckitt Benckiser Group Plc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Bronchiectasis Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Bronchiectasis Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bronchiectasis Drugs revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Bronchiectasis Drugs Market report?

Ans: The main players in the Bronchiectasis Drugs Market are Endo International Plc, GlaxoSmithKline Plc, Neopharma LLC, Pfizer Inc., Reckitt Benckiser Group Plc

What are the Application segmentation covered in the Bronchiectasis Drugs Market report?

Ans: The Applications covered in the Bronchiectasis Drugs Market report are Hospital, Research institute, Clinic, Other

What are the Type segmentation covered in the Bronchiectasis Drugs Market report?

Ans: The Types covered in the Bronchiectasis Drugs Market report are Antibiotics, Expectorants, Other drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchiectasis Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Antibiotics
1.2.3 Expectorants
1.2.4 Other drugs
1.3 Market by Application
1.3.1 Global Bronchiectasis Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Research institute
1.3.4 Clinic
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bronchiectasis Drugs Market Perspective (2019-2030)
2.2 Global Bronchiectasis Drugs Growth Trends by Region
2.2.1 Bronchiectasis Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bronchiectasis Drugs Historic Market Size by Region (2019-2024)
2.2.3 Bronchiectasis Drugs Forecasted Market Size by Region (2025-2030)
2.3 Bronchiectasis Drugs Market Dynamics
2.3.1 Bronchiectasis Drugs Industry Trends
2.3.2 Bronchiectasis Drugs Market Drivers
2.3.3 Bronchiectasis Drugs Market Challenges
2.3.4 Bronchiectasis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Bronchiectasis Drugs by Players
3.1.1 Global Bronchiectasis Drugs Revenue by Players (2019-2024)
3.1.2 Global Bronchiectasis Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Bronchiectasis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Bronchiectasis Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Bronchiectasis Drugs Market Concentration Ratio
3.4.1 Global Bronchiectasis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchiectasis Drugs Revenue in 2023
3.5 Global Key Players of Bronchiectasis Drugs Head office and Area Served
3.6 Global Key Players of Bronchiectasis Drugs, Product and Application
3.7 Global Key Players of Bronchiectasis Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bronchiectasis Drugs Breakdown Data by Type
4.1 Global Bronchiectasis Drugs Historic Market Size by Type (2019-2024)
4.2 Global Bronchiectasis Drugs Forecasted Market Size by Type (2025-2030)
5 Bronchiectasis Drugs Breakdown Data by Application
5.1 Global Bronchiectasis Drugs Historic Market Size by Application (2019-2024)
5.2 Global Bronchiectasis Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bronchiectasis Drugs Market Size (2019-2030)
6.2 North America Bronchiectasis Drugs Market Size by Type
6.2.1 North America Bronchiectasis Drugs Market Size by Type (2019-2024)
6.2.2 North America Bronchiectasis Drugs Market Size by Type (2025-2030)
6.2.3 North America Bronchiectasis Drugs Market Share by Type (2019-2030)
6.3 North America Bronchiectasis Drugs Market Size by Application
6.3.1 North America Bronchiectasis Drugs Market Size by Application (2019-2024)
6.3.2 North America Bronchiectasis Drugs Market Size by Application (2025-2030)
6.3.3 North America Bronchiectasis Drugs Market Share by Application (2019-2030)
6.4 North America Bronchiectasis Drugs Market Size by Country
6.4.1 North America Bronchiectasis Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Bronchiectasis Drugs Market Size by Country (2019-2024)
6.4.3 North America Bronchiectasis Drugs Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Bronchiectasis Drugs Market Size (2019-2030)
7.2 Europe Bronchiectasis Drugs Market Size by Type
7.2.1 Europe Bronchiectasis Drugs Market Size by Type (2019-2024)
7.2.2 Europe Bronchiectasis Drugs Market Size by Type (2025-2030)
7.2.3 Europe Bronchiectasis Drugs Market Share by Type (2019-2030)
7.3 Europe Bronchiectasis Drugs Market Size by Application
7.3.1 Europe Bronchiectasis Drugs Market Size by Application (2019-2024)
7.3.2 Europe Bronchiectasis Drugs Market Size by Application (2025-2030)
7.3.3 Europe Bronchiectasis Drugs Market Share by Application (2019-2030)
7.4 Europe Bronchiectasis Drugs Market Size by Country
7.4.1 Europe Bronchiectasis Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Bronchiectasis Drugs Market Size by Country (2019-2024)
7.4.3 Europe Bronchiectasis Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Bronchiectasis Drugs Market Size (2019-2030)
8.2 China Bronchiectasis Drugs Market Size by Type
8.2.1 China Bronchiectasis Drugs Market Size by Type (2019-2024)
8.2.2 China Bronchiectasis Drugs Market Size by Type (2025-2030)
8.2.3 China Bronchiectasis Drugs Market Share by Type (2019-2030)
8.3 China Bronchiectasis Drugs Market Size by Application
8.3.1 China Bronchiectasis Drugs Market Size by Application (2019-2024)
8.3.2 China Bronchiectasis Drugs Market Size by Application (2025-2030)
8.3.3 China Bronchiectasis Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Bronchiectasis Drugs Market Size (2019-2030)
9.2 Asia Bronchiectasis Drugs Market Size by Type
9.2.1 Asia Bronchiectasis Drugs Market Size by Type (2019-2024)
9.2.2 Asia Bronchiectasis Drugs Market Size by Type (2025-2030)
9.2.3 Asia Bronchiectasis Drugs Market Share by Type (2019-2030)
9.3 Asia Bronchiectasis Drugs Market Size by Application
9.3.1 Asia Bronchiectasis Drugs Market Size by Application (2019-2024)
9.3.2 Asia Bronchiectasis Drugs Market Size by Application (2025-2030)
9.3.3 Asia Bronchiectasis Drugs Market Share by Application (2019-2030)
9.4 Asia Bronchiectasis Drugs Market Size by Region
9.4.1 Asia Bronchiectasis Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Bronchiectasis Drugs Market Size by Region (2019-2024)
9.4.3 Asia Bronchiectasis Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Endo International Plc
11.1.1 Endo International Plc Company Details
11.1.2 Endo International Plc Business Overview
11.1.3 Endo International Plc Bronchiectasis Drugs Introduction
11.1.4 Endo International Plc Revenue in Bronchiectasis Drugs Business (2019-2024)
11.1.5 Endo International Plc Recent Developments
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Details
11.2.2 GlaxoSmithKline Plc Business Overview
11.2.3 GlaxoSmithKline Plc Bronchiectasis Drugs Introduction
11.2.4 GlaxoSmithKline Plc Revenue in Bronchiectasis Drugs Business (2019-2024)
11.2.5 GlaxoSmithKline Plc Recent Developments
11.3 Neopharma LLC
11.3.1 Neopharma LLC Company Details
11.3.2 Neopharma LLC Business Overview
11.3.3 Neopharma LLC Bronchiectasis Drugs Introduction
11.3.4 Neopharma LLC Revenue in Bronchiectasis Drugs Business (2019-2024)
11.3.5 Neopharma LLC Recent Developments
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Bronchiectasis Drugs Introduction
11.4.4 Pfizer Inc. Revenue in Bronchiectasis Drugs Business (2019-2024)
11.4.5 Pfizer Inc. Recent Developments
11.5 Reckitt Benckiser Group Plc
11.5.1 Reckitt Benckiser Group Plc Company Details
11.5.2 Reckitt Benckiser Group Plc Business Overview
11.5.3 Reckitt Benckiser Group Plc Bronchiectasis Drugs Introduction
11.5.4 Reckitt Benckiser Group Plc Revenue in Bronchiectasis Drugs Business (2019-2024)
11.5.5 Reckitt Benckiser Group Plc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Endo International Plc.
GlaxoSmithKline PLC
Neopharma, Inc.
Pfizer Inc
Reckitt Benckiser Group Plc.
List of Tables
    Table 1. Global Bronchiectasis Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Antibiotics
    Table 3. Key Players of Expectorants
    Table 4. Key Players of Other drugs
    Table 5. Global Bronchiectasis Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Bronchiectasis Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Bronchiectasis Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Bronchiectasis Drugs Market Share by Region (2019-2024)
    Table 9. Global Bronchiectasis Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Bronchiectasis Drugs Market Share by Region (2025-2030)
    Table 11. Bronchiectasis Drugs Market Trends
    Table 12. Bronchiectasis Drugs Market Drivers
    Table 13. Bronchiectasis Drugs Market Challenges
    Table 14. Bronchiectasis Drugs Market Restraints
    Table 15. Global Bronchiectasis Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Bronchiectasis Drugs Revenue Share by Players (2019-2024)
    Table 17. Global Top Bronchiectasis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Drugs as of 2023)
    Table 18. Global Bronchiectasis Drugs Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Bronchiectasis Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Bronchiectasis Drugs, Headquarters and Area Served
    Table 21. Global Key Players of Bronchiectasis Drugs, Product and Application
    Table 22. Global Key Players of Bronchiectasis Drugs, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Bronchiectasis Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Bronchiectasis Drugs Revenue Market Share by Type (2019-2024)
    Table 26. Global Bronchiectasis Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Bronchiectasis Drugs Revenue Market Share by Type (2025-2030)
    Table 28. Global Bronchiectasis Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Bronchiectasis Drugs Revenue Share by Application (2019-2024)
    Table 30. Global Bronchiectasis Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Bronchiectasis Drugs Revenue Share by Application (2025-2030)
    Table 32. North America Bronchiectasis Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Bronchiectasis Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Bronchiectasis Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Bronchiectasis Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Bronchiectasis Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Bronchiectasis Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Bronchiectasis Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Bronchiectasis Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Bronchiectasis Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Bronchiectasis Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Bronchiectasis Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Bronchiectasis Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Bronchiectasis Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Bronchiectasis Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Bronchiectasis Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Bronchiectasis Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Bronchiectasis Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Bronchiectasis Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Bronchiectasis Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Bronchiectasis Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Bronchiectasis Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Bronchiectasis Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Bronchiectasis Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Bronchiectasis Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Bronchiectasis Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Bronchiectasis Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Endo International Plc Company Details
    Table 65. Endo International Plc Business Overview
    Table 66. Endo International Plc Bronchiectasis Drugs Product
    Table 67. Endo International Plc Revenue in Bronchiectasis Drugs Business (2019-2024) & (US$ Million)
    Table 68. Endo International Plc Recent Developments
    Table 69. GlaxoSmithKline Plc Company Details
    Table 70. GlaxoSmithKline Plc Business Overview
    Table 71. GlaxoSmithKline Plc Bronchiectasis Drugs Product
    Table 72. GlaxoSmithKline Plc Revenue in Bronchiectasis Drugs Business (2019-2024) & (US$ Million)
    Table 73. GlaxoSmithKline Plc Recent Developments
    Table 74. Neopharma LLC Company Details
    Table 75. Neopharma LLC Business Overview
    Table 76. Neopharma LLC Bronchiectasis Drugs Product
    Table 77. Neopharma LLC Revenue in Bronchiectasis Drugs Business (2019-2024) & (US$ Million)
    Table 78. Neopharma LLC Recent Developments
    Table 79. Pfizer Inc. Company Details
    Table 80. Pfizer Inc. Business Overview
    Table 81. Pfizer Inc. Bronchiectasis Drugs Product
    Table 82. Pfizer Inc. Revenue in Bronchiectasis Drugs Business (2019-2024) & (US$ Million)
    Table 83. Pfizer Inc. Recent Developments
    Table 84. Reckitt Benckiser Group Plc Company Details
    Table 85. Reckitt Benckiser Group Plc Business Overview
    Table 86. Reckitt Benckiser Group Plc Bronchiectasis Drugs Product
    Table 87. Reckitt Benckiser Group Plc Revenue in Bronchiectasis Drugs Business (2019-2024) & (US$ Million)
    Table 88. Reckitt Benckiser Group Plc Recent Developments
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Bronchiectasis Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Bronchiectasis Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Antibiotics Features
    Figure 4. Expectorants Features
    Figure 5. Other drugs Features
    Figure 6. Global Bronchiectasis Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Bronchiectasis Drugs Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Case Studies
    Figure 9. Research institute Case Studies
    Figure 10. Clinic Case Studies
    Figure 11. Other Case Studies
    Figure 12. Bronchiectasis Drugs Report Years Considered
    Figure 13. Global Bronchiectasis Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Bronchiectasis Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Bronchiectasis Drugs Market Share by Region: 2023 VS 2030
    Figure 16. Global Bronchiectasis Drugs Market Share by Players in 2023
    Figure 17. Global Top Bronchiectasis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Drugs as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Bronchiectasis Drugs Revenue in 2023
    Figure 19. North America Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Bronchiectasis Drugs Market Share by Type (2019-2030)
    Figure 21. North America Bronchiectasis Drugs Market Share by Application (2019-2030)
    Figure 22. North America Bronchiectasis Drugs Market Share by Country (2019-2030)
    Figure 23. United States Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Bronchiectasis Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Bronchiectasis Drugs Market Share by Type (2019-2030)
    Figure 27. Europe Bronchiectasis Drugs Market Share by Application (2019-2030)
    Figure 28. Europe Bronchiectasis Drugs Market Share by Country (2019-2030)
    Figure 29. Germany Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Bronchiectasis Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Bronchiectasis Drugs Market Share by Type (2019-2030)
    Figure 37. China Bronchiectasis Drugs Market Share by Application (2019-2030)
    Figure 38. Asia Bronchiectasis Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Bronchiectasis Drugs Market Share by Type (2019-2030)
    Figure 40. Asia Bronchiectasis Drugs Market Share by Application (2019-2030)
    Figure 41. Asia Bronchiectasis Drugs Market Share by Region (2019-2030)
    Figure 42. Japan Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Bronchiectasis Drugs Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Bronchiectasis Drugs Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Bronchiectasis Drugs Market Share by Country (2019-2030)
    Figure 52. Brazil Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Bronchiectasis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Endo International Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2019-2024)
    Figure 59. GlaxoSmithKline Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2019-2024)
    Figure 60. Neopharma LLC Revenue Growth Rate in Bronchiectasis Drugs Business (2019-2024)
    Figure 61. Pfizer Inc. Revenue Growth Rate in Bronchiectasis Drugs Business (2019-2024)
    Figure 62. Reckitt Benckiser Group Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2019-2024)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-33C941
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Respiratory Tract infections (RTIs) Treatment Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-6P6241
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Bronchiectasis Drugs Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-2M6354
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Chronic Bronchitis Treatment Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-24J7064
Thu Dec 26 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions